Late-stage prostate cancer in Syria: A call for decentralized and early detection systems.

F Fouad Nahhat (1Mayo Clinic, Division of Hematology/Oncology, Department of Internal Medicine, Phoenix, United States) A Ahmad Al-Bitar A Alhadi Alseoudi (Al-Bairouni University Hospital, Damascus, Syrian Arab Republic) R Radwan Al-Ahmad (Al-Bairouni University Hospital, Damascus, Syrian Arab Republic) R Rabie Alkhouli (Al-Bairouni University Hospital, Damascus, Syrian Arab Republic) F Fatima Al-Jojo (Al-Bairouni University Hospital, Damascus, Syrian Arab Republic)

Abstract

e23211 Background: The Syrian conflict, ongoing since 2011, has significantly disrupted healthcare delivery, particularly in oncology. With the destruction of many regional cancer centers, access to care has become centralized in Damascus, home to Al Bairouni University Hospital—the nation’s primary cancer referral facility. This study examines the geographic distribution and stage at diagnosis of prostate cancer patients, highlighting post-conflict disparities in access and outcomes. Methods: We conducted a retrospective chart review of all prostate cancer patients diagnosed at Al Bairouni University Hospital between January 2022 and December 2024. Data on age, residency, and stage at diagnosis were extracted and analyzed descriptively. Results: A total of 859 patients were included, with a mean age of 69 years (SD 9). Only 47% (n = 405) of patients resided in Damascus or its suburbs (Rif-Dimashq), while the majority (53%, n = 462) traveled from other governorates—most notably Aleppo (8.5%), Hama (9.1%), Homs (8.4%), and Al-Hasakah (6.2%). This geographic pattern reflects the collapse of regional oncology services due to prolonged conflict.Alarmingly, 65% of patients (n = 507) were diagnosed with metastatic disease (stage IV), while only 16% and 19% presented with localized and regional stages, respectively. This contrasts sharply with global trends and suggests systemic gaps in early detection. Contributing factors may include the absence of structured screening programs, weak insurance system and primary care infrastructure, low prostate cancer awareness, fear of cancer diagnosis, financial barriers, and limited healthcare access in rural areas. Conclusions: This study reveals the deep, lingering effects of war on prostate cancer care in Syria. The centralization of oncology services places undue burden on patients traveling long distances for care, while the predominance of advanced-stage diagnoses underscores the need for robust early detection efforts. These findings support urgent investment in rebuilding regional cancer infrastructure, expanding community-based health services, and improving access to timely diagnosis and treatment as the country enters a phase of reconstruction.

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (6)

F

Fouad Nahhat

1Mayo Clinic, Division of Hematology/Oncology, Department of Internal Medicine, Phoenix, United States

A

Ahmad Al-Bitar

A

Alhadi Alseoudi

Al-Bairouni University Hospital, Damascus, Syrian Arab Republic

R

Radwan Al-Ahmad

Al-Bairouni University Hospital, Damascus, Syrian Arab Republic

R

Rabie Alkhouli

Al-Bairouni University Hospital, Damascus, Syrian Arab Republic

F

Fatima Al-Jojo

Al-Bairouni University Hospital, Damascus, Syrian Arab Republic